Insider · CIK 0001559569

Pruzanski Mark

CIK 0001559569 Name as filed on the most recent filing

Filed as Pruzanski Mark (38)

89 transaction lines · from 38 filings · filed 2013-06-21 to 2020-01-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

89 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-12-31 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 12,500, disposed Open Form 4 filing 0001104659-20-001086
2019-12-26 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 52,125, disposed Open Form 4 filing 0001104659-19-076863
2019-11-26 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 3,543,700, disposed Open Form 4 filing 0001104659-19-068397
2019-11-25 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 1,456,300, disposed Open Form 4 filing 0001104659-19-068397
2018-11-16 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 4 lines 2,803,129, disposed Open Form 4 filing 0001144204-18-060579
2018-11-15 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 2 lines 2,250,585, disposed Open Form 4 filing 0001144204-18-060579
2018-04-09 P, Open-market purchase Intercept Pharmaceuticals IncICPT 499,968, acquired Open Form 4 filing 0001144204-18-019836
2017-10-02 S, Open-market sale Intercept Pharmaceuticals IncICPT 90,189, disposed Open Form 4 filing 0001144204-17-051413
2017-07-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 174,633, disposed Open Form 4 filing 0001144204-17-035811
2017-06-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 5 lines 5,231,864, disposed Open Form 4 filing 0001144204-17-034719
2017-04-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 137, disposed Open Form 4 filing 0001144204-17-019294
2017-01-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 291,181, disposed Open Form 4 filing 0001144204-17-000939
2016-10-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 115,056, disposed Open Form 4 filing 0001144204-16-127099
2016-09-20 S, Open-market sale Intercept Pharmaceuticals IncICPT 5,775,000, disposed Open Form 4 filing 0001144204-16-124959
2016-07-05 S, Open-market sale Intercept Pharmaceuticals IncICPT 103,608, disposed Open Form 4 filing 0001144204-16-112099
2016-04-04 S, Open-market sale Intercept Pharmaceuticals IncICPT 92,578, disposed Open Form 4 filing 0001144204-16-093112
2016-01-04 S, Open-market sale Intercept Pharmaceuticals IncICPT 2 lines 310,191, disposed Open Form 4 filing 0001144204-16-074237
2015-10-02 S, Open-market sale Intercept Pharmaceuticals IncICPT 26,560, disposed Open Form 4 filing 0001144204-15-058163
2015-07-10 S, Open-market sale Intercept Pharmaceuticals IncICPT 3,125,000, disposed Open Form 4 filing 0001144204-15-042554
2015-07-02 S, Open-market sale Intercept Pharmaceuticals IncICPT 3 lines 37,328, disposed Open Form 4 filing 0001144204-15-041465
2015-05-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 1,500,000, disposed Open Form 4 filing 0001144204-15-032148
2015-05-01 S, Open-market sale Intercept Pharmaceuticals IncICPT 8 lines 3,169,495, disposed Open Form 4 filing 0001144204-15-027775
2015-04-02 S, Open-market sale Intercept Pharmaceuticals IncICPT 43,599, disposed Open Form 4 filing 0001144204-15-021234
2015-01-05 S, Open-market sale Intercept Pharmaceuticals IncICPT 81,360, disposed Open Form 4 filing 0001144204-15-001257
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 825,300, disposed Open Form 4 filing 0001144204-14-065432
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 772,034, disposed Open Form 4 filing 0001144204-14-065432
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 285,420, disposed Open Form 4 filing 0001144204-14-065432
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 131,231, disposed Open Form 4 filing 0001144204-14-065432
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 127,146, disposed Open Form 4 filing 0001144204-14-065432
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 103,184, disposed Open Form 4 filing 0001144204-14-065432
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 96,308, disposed Open Form 4 filing 0001144204-14-065432
2014-11-03 S, Open-market sale Intercept Pharmaceuticals IncICPT 76,589, disposed Open Form 4 filing 0001144204-14-065432

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 88
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Pruzanski Mark, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001559569

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.